Satellos Bioscience (MSLE) Other financing activities (2025 - 2026)
Satellos Bioscience (MSLE) posted quarterly Other financing activities of $51.9 million for Q1 2026, up 2594950.0% year-over-year from N/an in Q1 2025, and up 2594950.0% quarter-over-quarter from $2000.0 in Q1 2025.
Satellos Bioscience (MSLE) Other financing activities (2025 - 2026) Analysis & Trends
Satellos Bioscience (MSLE) has reported Other financing activities for 2 consecutive years, with $51.9 million the latest figure, recorded in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.50 Bn | 131.65 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.10 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.59 Bn | 60.41 Bn | 1.37 Bn |
| 4 | Moderna | 56.75 Bn | 51.62 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.64 Bn | 28.33 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.80 Bn | 9.41 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - |
| 10 | Satellos Bioscience | 207.48 Mn | 207.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51.90 Mn |
| Mar 31, 2026 | 51.90 Mn |
| Mar 31, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |